The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.15
Bid: 27.90
Ask: 28.10
Change: 0.45 (1.62%)
Spread: 0.20 (0.717%)
Open: 28.00
High: 28.50
Low: 27.65
Prev. Close: 27.70
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

28 Apr 2022 11:00

RNS Number : 7156J
IQE PLC
28 April 2022
 

IQE plc

 

Cardiff, UK

28 April 2022

 

Director/PDMR Shareholding

 

IQE plc (AIM: IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, was notified on 27 April 2022 that on that date Dr Drew Nelson, President and Non-Executive of the Company, purchased 250,000 ordinary shares of 1 pence each in the Company ("Ordinary Shares").

This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the Person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA")

a)

Name

Dr Drew Nelson

2.

Reason for the notification

a)

Position / status

PDMR (President and Non-Executive Director)

b)

Initial notification / amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IQE plc

 

b)

Legal Entity Identifier

213800Y33WHD3ESJJP16

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of 1 pence each in the CompanyGB0009619924

 

b)

Nature of the transaction

Purchase of Ordinary Shares

 

c)

Price(s) and volume(s)

250,000 Ordinary Shares at an average price of 30.2p per Ordinary Share

d)

Aggregated information

·  Aggregated volume

·  Aggregated price

Aggregated volume: 250,000

Aggregated price: £75,500

e)

Date of the transaction(s)

27 April 2022

 

f)

Place of the transaction

London Stock Exchange, AIM (AIMX)

 

 

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Tim Pullen

Amy Barlow

Peel Hunt LLP (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Edward Knight

Paul Gillam

James Smith

Citigroup Global Markets Limited (Joint Broker)

+44 (0) 20 7986 4000

Christopher Wren

Peter Catterall

 

Headland Consultancy (Financial PR)+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Antonia Pollock: +44 (0) 7789 954 356

 

ABOUT IQE

http://iqep.com

 

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

 

· handset devices

· global telecoms infrastructure

· connected devices

· 3D sensing

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with c. 670 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEMSUAEESELL
Date   Source Headline
31st Dec 20189:00 amGNWIQE plc: Holding(s) in Company
21st Dec 20184:30 pmGNWIQE plc: Holding(s) in Company
21st Dec 20184:00 pmGNWIQE plc: Holding(s) in Company
12th Dec 20184:00 pmGNWIQE plc: Holding(s) in Company
10th Dec 20182:00 pmGNWIQE plc: Holding(s) in Company
30th Nov 20184:00 pmGNWIQE plc:Total voting rights
15th Nov 20184:00 pmGNWIQE plc: Holding(s) in Company
14th Nov 20184:00 pmGNWIQE plc: Holding(s) in Company
13th Nov 20187:00 amGNWTrading update and comment on VCSEL supply chain
12th Nov 20184:40 pmRNSSecond Price Monitoring Extn
12th Nov 20184:35 pmRNSPrice Monitoring Extension
12th Nov 20184:20 pmGNWTrading update
7th Nov 201812:00 pmGNWHolding(s) in Company
5th Nov 20184:00 pmGNWIQE plc: Holding(s) in Company
31st Oct 20184:00 pmGNWTotal Voting Rights
29th Oct 20184:00 pmGNWIQE plc: Holding(s) in Company
29th Oct 20184:00 pmGNWIQE plc: Holding(s) in Company
22nd Oct 201810:00 amGNWIQE plc: Holding(s) in Company
17th Oct 20184:00 pmGNWIQE plc: Holding(s) in Company
15th Oct 20187:00 amGNWIQE plc: Directorate change
28th Sep 201812:00 pmGNWIQE plc: Total voting rights
7th Sep 201812:00 pmGNWHolding(s) in Company
10th Jul 20184:00 pmGNWHolding(s) in Company
9th Jul 20187:00 amRNSKey NanoImprint Lithography Milestone
29th Jun 20184:00 pmGNWTotal Voting Rights
4th Jun 20184:30 pmGNWResult of AGM
4th Jun 20187:00 amGNWAGM Statement
1st Mar 20187:00 amRNSIQE wins place at GREAT innovation Festival
22nd Feb 20187:00 amRNSCSC announces joint programme with partner ICS Ltd
8th Feb 201812:07 pmRNSSecond Price Monitoring Extn
8th Feb 201812:02 pmRNSPrice Monitoring Extension
21st Dec 20177:00 amRNSIQE Group expands IP portfolio
20th Jul 20174:35 pmRNSPrice Monitoring Extension
12th Jun 20177:00 amRNSCardiff hosts international VCSEL technology event
1st Jun 20177:00 amRNSIQE wins 2017 Raytheon Supplier Award
29th Nov 20168:04 amRNSIQE and BLUGLASS announce strategic partnership
17th May 20167:00 amRNSIQE news update from CS-Mantech conference
16th May 20167:00 amRNSIQE Joins imec's GaN-on-Si Program
19th Apr 20167:16 amRNSIQE joins EUR15m project
17th Feb 20167:05 amRNSProfessor Colin Whitehouse appointed as CSC Chair
8th Jan 20167:01 amRNSCompound Semiconductor Catapult Centre announced
7th Oct 20157:00 amRNSIQE's GaN on Si achieves breakthrough results
30th Jul 201511:00 amRNSIQE key partner in US Integrated Photonics program
21st Apr 20157:00 amRNSIncreasing demand for IQE's Infrared products
31st Mar 20147:00 amRNS200mm GaN on Silicon for next generation CMOS
19th Mar 20147:00 amRNSIQE delivers 150mm (6") VCSEL epiwafers
13th Mar 20147:00 amRNSIQE's VCSEL wafers enable record performance
11th Mar 20147:20 amRNSPresentation at OFC
22nd Aug 20137:00 amRNSIQE reports new CPV cell efficiency
5th Jun 20132:22 pmRNSMerger Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.